Influence of peroxisome proliferator-activated receptor alpha agonists on the intracellular turnover and secretion of apolipoprotein (Apo) B-100 and ApoB-48.
about
The blind men 'see' the elephant-the many faces of fatty liver diseaseHuman apoB contributes to increased serum total apo(a) level in LPA transgenic miceApolipoprotein B: a clinically important apolipoprotein which assembles atherogenic lipoproteins and promotes the development of atherosclerosisActivation of peroxisome proliferator-activated receptor alpha increases the expression and activity of microsomal triglyceride transfer protein in the liverLiver fatty acid-binding protein and obesity.Transcriptomic signatures of peroxisome proliferator-activated receptor α (PPARα) in different mouse liver models identify novel aspects of its biology.Health implications of high dietary omega-6 polyunsaturated Fatty acids.Hepatitis B Virus X Protein Induces Hepatic Steatosis by Enhancing the Expression of Liver Fatty Acid Binding ProteinFasting-induced liver GADD45β restrains hepatic fatty acid uptake and improves metabolic healthHigh feeding intensity increases the severity of fatty liver in the American mink (Neovison vison) with potential ameliorating role for long-chain n-3 polyunsaturated fatty acids.Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production.The importance of the long-chain polyunsaturated fatty acid n-6/n-3 ratio in development of non-alcoholic fatty liver associated with obesity.Intestinal fatty acid binding protein regulates mitochondrion beta-oxidation and cholesterol uptake.Hypoxia-inducible lipid droplet-associated (HILPDA) is a novel peroxisome proliferator-activated receptor (PPAR) target involved in hepatic triglyceride secretion.Liver metabolic disruption induced after a single exposure to PCB126 in rats.Fenofibrate increases very low density lipoprotein triglyceride production despite reducing plasma triglyceride levels in APOE*3-Leiden.CETP mice.Peroxisome proliferator activated receptors and lipoprotein metabolism.Decreased liver fatty acid binding capacity and altered liver lipid distribution in mice lacking the liver fatty acid-binding protein gene.Altered triglyceride-rich lipoprotein production in Zucker diabetic fatty rats.The peroxisome proliferator-activated receptor alpha (PPARalpha) agonist ciprofibrate inhibits apolipoprotein B mRNA editing in low density lipoprotein receptor-deficient mice: effects on plasma lipoproteins and the development of atherosclerotic leStatin induction of liver fatty acid-binding protein (L-FABP) gene expression is peroxisome proliferator-activated receptor-alpha-dependent.Phospholipid transfer protein deficiency impairs apolipoprotein-B secretion from hepatocytes by stimulating a proteolytic pathway through a relative deficiency of vitamin E and an increase in intracellular oxidants.PPARalpha activation increases triglyceride mass and adipose differentiation-related protein in hepatocytes.High fat diet-induced oxidative stress blocks hepatocyte nuclear factor 4α and leads to hepatic steatosis in mice.Peroxisome proliferator-activated receptor alpha polymorphisms and postprandial lipemia in healthy men.
P2860
Q24654991-5A53AD95-F66F-41C1-A4F0-5C65DBACB18BQ24796498-093A5739-CCF6-4007-98BA-9A34F3313630Q28278173-2FA1EE6F-44F4-4BAF-8485-7015B82E247AQ28570588-E79C817D-2456-4597-8CD5-83C53FFE6230Q34120131-5DF58267-0A9B-42DA-9213-431E48571FD0Q35228774-5FDB2DC4-D428-490D-A510-F7A65A603AEBQ35909254-62470296-5830-487F-A711-64074BF39973Q36523963-9A4A1885-6FFA-4AB4-9491-7AA8DFBC8993Q36955992-0EFD551D-1695-4F7D-BBDA-8AAFA570C014Q37497094-B203EB75-86BC-4EAE-B622-64615D6AC632Q37698834-3079ED1C-1A0E-4248-B21A-46C857313EB1Q37947064-FF0EC174-440D-4EA4-B10B-CE5E2EECEDCBQ38294056-60B98493-BDD1-4E65-984E-858F26190EBCQ38990185-FD14E3D9-2F66-4583-861A-6D7980150A81Q39233272-3C2073A6-EE6D-41D9-9C99-628FE20D4E28Q42175229-BA26FB84-7ED0-4119-8DD0-56957622EA6EQ42988793-47F1A6B3-AE0B-4191-A58A-80DBC537ED1BQ44387480-66A99AFD-E03C-4DFC-9575-2EB7767B0055Q44768336-0965BC38-B8DB-4273-9D3E-2AC2FE0DE222Q44881213-572CED3E-11EA-4D3F-93B7-61C9FFD4BFF9Q45037103-BC39EF82-304C-45FF-9838-24D0C4D5B8D0Q45285259-17C55867-696F-4A08-8E70-5DDDF21310E8Q46799921-4C800165-3187-421B-B030-CE67B38E04B8Q47389741-1A96A5EC-A36E-4C14-8E97-DCCE83941568Q51475711-26E276E7-F370-490C-B157-A8F6D721E39D
P2860
Influence of peroxisome proliferator-activated receptor alpha agonists on the intracellular turnover and secretion of apolipoprotein (Apo) B-100 and ApoB-48.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Influence of peroxisome prolif ...... otein (Apo) B-100 and ApoB-48.
@en
type
label
Influence of peroxisome prolif ...... otein (Apo) B-100 and ApoB-48.
@en
prefLabel
Influence of peroxisome prolif ...... otein (Apo) B-100 and ApoB-48.
@en
P2093
P2860
P356
P1476
Influence of peroxisome prolif ...... otein (Apo) B-100 and ApoB-48.
@en
P2093
Catharina Claesson
Daniel Lindén
Jan Oscarsson
Karin Lindberg
Lennart Asp
Maria Gustafsson
P2860
P304
23044-23053
P356
10.1074/JBC.M110416200
P407
P577
2002-03-29T00:00:00Z